CentreForMedicalHumanities.org Editorial Team | April 28, 2026 | Affiliate Disclosure: This article contains affiliate links. A commission may be earned if a purchase is made through links in this article at no additional cost to the reader.
These statements have not been evaluated by the Food and Drug Administration. Supplements are not intended to diagnose, treat, cure, or prevent any disease. This article is for informational and educational purposes only and does not constitute medical advice.
NeuroSalt vs ALA vs Benfotiamine: Which Is Right for You?
These four supplements — NeuroSalt, alpha-lipoic acid, benfotiamine, and Nervive — target nerve pain through completely different mechanisms and suit completely different situations. Choosing based on price or marketing is the wrong frame. The right frame is mechanism-to-cause matching: which formula's pathway aligns with what's actually driving your nerve symptoms?
Neuropathic pain affects an estimated 7–10% of the global population, according to reviews in The Lancet and Pain, and remains inadequately treated in roughly half of patients on first-line pharmaceutical therapy. The supplement category exists partly because that gap is real. But which supplement addresses which gap depends entirely on the underlying cause — and that's what this comparison covers.
NeuroSalt: The Botanical Neural Calming Approach
NeuroSalt uses five botanical ingredients — Passionflower 145 mg, Marshmallow Root 110 mg, Corydalis 100 mg, Prickly Pear Extract 50 mg, California Poppy Seed 45 mg — to address neuropathic discomfort through calming, antioxidant, and pain-signal modulation pathways. It contains no B vitamins, no alpha-lipoic acid, no benfotiamine, no magnesium, and no acetyl-L-carnitine. This is important to establish clearly because several published NeuroSalt reviews in 2026 have incorrectly attributed those ingredients to the formula — they are not in it.
What NeuroSalt's approach does: the Corydalis component addresses neural hyperactivity through dopamine D2 receptor antagonism, a mechanism that published research (PLOS ONE, UC Irvine, 2016) found attenuates neuropathic pain without inducing tolerance. The passionflower and California poppy seed components address the neural excitability and sleep disruption dimensions of neuropathic pain through GABAergic pathways. Prickly pear contributes antioxidant activity against oxidative stress in peripheral nerve tissue.
Best fit for: Adults with idiopathic neuropathy (no clear underlying cause identified), or those whose nerve discomfort has a significant anxiety, neural hyperactivity, or sleep disruption component. Also relevant for people who have already tried B-vitamin approaches without adequate relief and are looking for a mechanistically distinct option. The calming botanical formula also distinguishes itself from stimulant-adjacent formulas for people sensitive to anything energizing.
Evidence base: Ingredient-level research is legitimate, particularly for Corydalis. No published clinical trial has evaluated the completed five-ingredient formula. 60-day money-back guarantee allows a proper evaluation window. Pricing: $49–$79 per bottle depending on quantity, sold through ClickBank.
Key limitation: Not the right choice if B-vitamin deficiency or mitochondrial energy pathway impairment is the primary driver of nerve symptoms. CNS interaction considerations with prescription sedatives apply — see our full safety overview at NeuroSalt safety and drug interactions: a clinical review.
Alpha-Lipoic Acid: The Evidence Standard for Diabetic Neuropathy
Alpha-lipoic acid (ALA) is a dual-soluble (water and fat) antioxidant naturally produced in the body and concentrated in mitochondria. It has been the subject of multiple randomized controlled trials for diabetic peripheral neuropathy — more rigorous clinical trial evidence exists for ALA than for any other supplement approach to neuropathic pain. The SYDNEY and SYDNEY 2 trials, both published in peer-reviewed neurology journals, demonstrated significant symptom improvement in diabetic neuropathy patients at doses of 600 mg three times daily over 3–5 weeks. The mechanism: ALA reduces oxidative stress in peripheral nerve mitochondria, inhibits pro-inflammatory cytokine production, and may improve nerve blood flow.
Best fit for: Adults with confirmed or probable diabetic peripheral neuropathy where oxidative stress and glucose-related nerve damage are the documented primary drivers. The evidence base is specifically strongest for this population.
Evidence base: The strongest in the supplement category for neuropathic pain. Multiple RCTs with specific results. The therapeutic dosage in trials (600–1,800 mg daily) is substantially higher than what many off-the-shelf supplements provide — check the dose on any ALA product before purchasing.
Key limitation: The clinical trial evidence is concentrated in diabetic neuropathy. Evidence for other neuropathy types is less established. ALA can lower blood glucose modestly — anyone on insulin or sulfonylureas needs to monitor glucose when starting. Rash and gastrointestinal effects have been reported at high doses.
Benfotiamine: The Targeted Thiamine Approach
Benfotiamine is a fat-soluble synthetic derivative of thiamine (vitamin B1). Unlike standard thiamine, benfotiamine crosses nerve cell membranes efficiently, producing intracellular thiamine concentrations that standard oral B1 does not reliably achieve. Published research, including controlled trials in diabetic neuropathy, shows that benfotiamine blocks three of the four biochemical pathways through which excess glucose damages peripheral nerve tissue — the polyol pathway, the advanced glycation end-product (AGE) pathway, and the hexosamine pathway. This makes it one of the most mechanistically targeted neuropathy supplements available.
Best fit for: Adults with diabetic neuropathy or suspected thiamine metabolism insufficiency. Also relevant for people with a history of alcohol use, since alcohol depletes thiamine. The mechanistic specificity is a strength for the right population and less relevant for those whose neuropathy isn't glucose or thiamine-pathway driven.
Evidence base: Solid controlled trial data for diabetic neuropathy specifically. Less evidence for idiopathic or non-diabetic neuropathy. Typically used at 300–600 mg daily.
Key limitation: Highly pathway-specific. Less relevant if the nerve symptoms aren't connected to glucose dysregulation or thiamine status. Standard B1 in a B-complex supplement is not an equivalent substitute — the fat-solubility is what produces the intracellular effect.
Nervive: The Accessible Combination Approach
Nervive is a widely distributed retail supplement (available at major pharmacy chains without a prescription) containing alpha-lipoic acid, thiamine (B1), pyridoxine (B6), and cobalamin (B12), along with turmeric extract. Its formulation targets both the B-vitamin deficiency pathway and the oxidative stress pathway in a single product. It is positioned as a daily maintenance supplement rather than a therapeutic-dose intervention.
Best fit for: Adults who want a broad-spectrum B-vitamin and antioxidant approach without committing to the higher-dose, single-ingredient therapeutic model. Practical for people without a specific identified neuropathy driver who want to cover multiple nutritional bases. The retail availability without a prescription or online-only purchase adds accessibility.
Evidence base: The individual ingredients have established research bases; the finished formula has not been evaluated in a clinical trial at the doses provided. The ALA dose in Nervive is lower than the therapeutic dose used in the SYDNEY trials — important context for expectations.
Key limitation: Contains B6, which at excessive doses can itself cause or worsen peripheral neuropathy. Nervive's B6 content is within safe daily limits, but this is why B6 supplementation requires awareness of cumulative dosing if other B-complex products are also being taken. The ALA dose likely falls below the range studied in major clinical trials.
Comparison Decision Framework: Which Approach for Which Situation
These supplements aren't really competing for the same buyer — they suit different clinical pictures.
If your nerve symptoms are associated with diabetes or prediabetes and oxidative/mitochondrial nerve damage is the documented mechanism: alpha-lipoic acid at therapeutic doses has the strongest published evidence base. Benfotiamine adds complementary pathway coverage.
If B12 deficiency has been identified by bloodwork: targeted B12 repletion — at doses sufficient to bypass absorption limitations (often 1,000 mcg oral methylcobalamin or sublingual/injectable forms) — addresses the documented cause directly. A supplement stack doesn't substitute for addressing a confirmed deficiency.
If neuropathy is idiopathic, has a significant anxiety or sleep disruption component, or if B-vitamin approaches have already been tried without adequate relief: NeuroSalt's botanical mechanism (Corydalis-based pain modulation, GABAergic calming) offers a mechanistically distinct option that some adults find more appropriate for their specific picture. For the full formula evaluation, see NeuroSalt 2026: ingredients, pink salt trick, is it legit?.
If you're on multiple medications and want to minimize interaction risk: review the interaction profiles of all options before choosing. The safety article at NeuroSalt safety and drug interactions covers the botanical interaction picture specifically. ALA and B vitamins have their own interaction considerations, particularly with glucose-lowering medications and with B6 toxicity at high cumulative doses.
When None of These Is Right
If nerve symptoms are progressive, worsening, or affecting motor function — supplements of any kind are not the appropriate primary intervention. Referral to a neurologist, investigation for systemic causes, and medication management belong at the center of that picture. Supplements are adjuncts to an established clinical plan, not replacements for one. For a fuller discussion of when to escalate beyond self-directed supplement research, see when standard nerve treatments fall short: what to do next.
If you've reviewed the full context above and want to evaluate NeuroSalt specifically: view current NeuroSalt program details.
These statements have not been evaluated by the Food and Drug Administration. Supplements are not intended to diagnose, treat, cure, or prevent any disease. This article is for informational and educational purposes only and does not constitute medical advice. Individual results vary. Consult a licensed healthcare professional before starting any supplement.